Abiopharma

(10% Negative) FULCRUM THERAPEUTICS, INC. (FULC) Announces Business Combination

Director Wesemann William 🟢 acquired 2.1K shares of Aclarion, Inc. (ACON) at $2.34 Transaction Date: Aug 13, 2026 | Filing ID: 006514

Director Neal David K 🟢 acquired 7.5K shares of Aclarion, Inc. (ACON) at $2.40 Transaction Date: Aug 13, 2026 | Filing ID: 006513

Director Ness Brent 🟢 acquired 5.2K shares of Aclarion, Inc. (ACON) at $2.31 Transaction Date: Aug 13, 2026 | Filing ID: 006512

The9 Limited to Report Second Quarter 2026 Results on August 24, 2026

XPEL and Will Castro Return for Season 2 of 'Unique Academy USA,' Expanding Reach of Transformative Automotive Career Program

Investview, Inc. Reports Second-Quarter 2026 Financial Results and Strategic Business Update

Supply & Demand Chain Executive Names Two RXO Leaders as Recipients of 2026 Women in Supply Chain Forum™ Award

Uber and Zipline Partner to Bring Drone Delivery to Millions of Americans

OSI Systems Awarded $200 Million IDIQ Contract From Customs and Border Protection for Relocatable Vehicle Inspection Systems

Cloudastructure Reports 164% Year-Over-Year Growth in Subscription Revenue for the Second Quarter 2026

Ventas Releases 2025-2026 Corporate Sustainability Report

Corporación América Airports S.A. Reports July 2026 Passenger Traffic

Canna-Global Acquisition Corp. Announces Initial Partial Liquidating Distribution

IMAX Soars to $47 Million Global Weekend as Christopher Nolan’s The Odyssey Delivers Strong Debut in China